Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter April 1, 2012

Molecular mechanisms of glycine transporter GlyT2 mutations in startle disease

  • Victoria M. James , Jennifer L. Gill , Maya Topf and Robert J. Harvey EMAIL logo
From the journal Biological Chemistry

Abstract

Startle disease affects newborn children and involves an exaggerated startle response and muscle hypertonia in response to acoustic or tactile stimuli. The primary cause of startle disease is defective inhibitory glycinergic transmission due to mutations in the postsynaptic glycine receptor (GlyR) α1 subunit gene (GLRA1). However, mutations have also been discovered in the genes encoding the GlyR β subunit (GLRB) and the presynaptic glycine transporter GlyT2 (SLC6A5). GlyT2 mutations have also been detected in Belgian Blue cattle and Irish Wolfhounds, where they have significant economic and animal welfare impacts.


Corresponding author

Received: 2011-10-22
Accepted: 2011-11-17
Published Online: 2012-04-01
Published in Print: 2012-04-01

©2012 by Walter de Gruyter Berlin Boston

Downloaded on 12.6.2024 from https://www.degruyter.com/document/doi/10.1515/bc-2011-232/html
Scroll to top button